A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE)
Clinical trial NCT05900388 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05900388
- Sponsor
- Bayer
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-09-01
- Primary completion
- 2029-06-30
- Enrollment
- 850
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.